Financial reports
ARS
2023 FY
Annual report to shareholders
21 Mar 24
10-K
2023 FY
Annual report
28 Feb 24
10-Q
2023 Q3
Quarterly report
8 Nov 23
10-Q
2023 Q2
Quarterly report
9 Aug 23
10-Q
2023 Q1
Quarterly report
10 May 23
ARS
2022 FY
Annual report to shareholders
23 Mar 23
10-K
2022 FY
Annual report
27 Feb 23
10-Q
2022 Q3
Quarterly report
7 Nov 22
10-Q
2022 Q2
Quarterly report
8 Aug 22
10-Q
2022 Q1
Quarterly report
9 May 22
Current reports
8-K
Departure of Directors or Certain Officers
21 Mar 24
8-K
IFF Announces Sale of its Pharma Solutions Business to Roquette
19 Mar 24
8-K
IFF Reports Fourth Quarter and Full Year 2023 Results
20 Feb 24
8-K
Departure of Directors or Certain Officers
7 Feb 24
8-K
Results of Operations and Financial Condition
18 Jan 24
8-K
Departure of Directors or Certain Officers
11 Jan 24
8-K
Amendments to Articles of Incorporation or Bylaws
7 Nov 23
8-K
IFF Reports Third Quarter 2023 Results
6 Nov 23
8-K
Entry into a Material Definitive Agreement
19 Sep 23
8-K
IFF Reports Second Quarter 2023 Results
7 Aug 23
Registration and prospectus
25-NSE
Exchange delisting
14 Mar 24
S-8
Registration of securities for employees
29 Feb 24
S-8
Registration of securities for employees
29 Nov 22
25-NSE
Exchange delisting
27 Sep 21
25-NSE
Exchange delisting
15 Sep 21
S-8 POS
Registration of securities for employees (post-effective amendment)
5 May 21
S-8
Registration of securities for employees
5 May 21
S-8
Registration of securities for employees
2 Feb 21
425
Business combination disclosure
1 Feb 21
425
Business combination disclosure
26 Jan 21
Proxies
DEFR14A
Revised proxy
1 Apr 24
DEFA14A
Additional proxy soliciting materials
21 Mar 24
DEF 14A
Definitive proxy
21 Mar 24
DEFA14A
Additional proxy soliciting materials
12 Apr 23
DEFA14A
Additional proxy soliciting materials
23 Mar 23
DEF 14A
Definitive proxy
23 Mar 23
DEFA14A
Additional proxy soliciting materials
25 Mar 22
DEF 14A
Definitive proxy
25 Mar 22
DEFA14A
Additional proxy soliciting materials
23 Mar 21
DEF 14A
Definitive proxy
23 Mar 21
Other
EFFECT
Notice of effectiveness
4 Jan 21
CORRESP
Correspondence with SEC
29 Dec 20
UPLOAD
Letter from SEC
28 Jul 20
CORRESP
Correspondence with SEC
24 Jul 20
UPLOAD
Letter from SEC
22 Jul 20
CORRESP
Correspondence with SEC
23 Jun 20
CORRESP
Correspondence with SEC
23 Jun 20
UPLOAD
Letter from SEC
5 Jun 20
UPLOAD
Letter from SEC
5 Jun 20
CERT
Certification of approval for exchange listing
27 Sep 18
Ownership